About This Study
The purpose of this study is to test a new mix of three drugs called lenalidomide, mosunetuzumab, and polatuzumab vedotin. We want to see if these drugs are safe and helpful for people with a type of blood cancer called diffuse large B-cell lymphoma. This study is for patients whose cancer has come back or did not get better with other treatments. We also want to find the highest dose that is still safe for patients.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
- Diary/e-Diary Writing or Recordings
Age & Gender
- 18 - 100 years old
- All Genders
Language
- This study enrolls English speakers only
Additional Study Information
- No compensation provided
- No reimbursement offered
Study Locations
- Greater Winston-Salem, NC